Physician profile
Ranjan Ray
NPI 1033376017
$2,698.10
in general payments reported to CMS, 2019-2025
22 companies · $323 in 2025
The $323 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,068 · 2020: $359 · 2021: $340 · 2022: $75.22 · 2023: $53.54 · 2024: $479 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $613.68 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $450.12 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $367.55 | 2019-2021 | |
| Amgen INC. | $244.34 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $128.88 | 2024 | Optimizer |
| Abiomed | $123.40 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.30 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $89.63 | 2021-2024 | Camzyos |
| Irhythm Technologies, INC. | $74.93 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Janssen Pharmaceuticals, INC | $55.45 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $46.60 | 2024-2025 | |
| Pfizer INC. | $45.99 | 2020-2025 | |
| Heartflow, INC. | $45.10 | 2019-2021 | |
| Baxter Healthcare | $44.27 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Paragonix Technologies, INC. | $43.88 | 2025 | Sherpapak |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $42.82 | 2019 | |
| Cvrx, INC. | $31.86 | 2024 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $31.27 | 2019 | |
| One Lambda, INC. | $28.72 | 2024 | |
| Alnylam Pharmaceuticals INC. | $28.30 | 2025 | Onpattro |
| Cathworks, INC. | $26.32 | 2020 | |
| Boston Scientific Corporation | $21.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranjan Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.